Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome
- PMID: 27602130
- PMCID: PMC4998582
- DOI: 10.3892/ol.2016.4816
Hsa-miR-137, hsa-miR-520e and hsa-miR-590-3p perform crucial roles in Lynch syndrome
Abstract
The aim of the present study was to identify the differentially expressed microRNAs (DEMs) between Lynch syndrome (LS) and the normal colonic (N-C) control samples, predict the target genes (TGs) and analyze the potential functions of the DEMs and TGs. The miRNA expression dataset GSE30454, which included data of 13 LS and 20 N-C tissue samples, was downloaded from the Gene Expression Omnibus. The classical t-test in Linear Models for Microarray Data package was used for DEM identification. TG prediction was performed using 5 databases. The regulatory network of the DEMs and their TGs was constructed using Cytoscape. Functional and pathway enrichment analysis was performed. The transcription factors (TFs), tumor-associated genes (TAG) and tumor suppressor genes (TSGs) were then identified. Three key DEMs hsa-miR-137, hsa-miR-520e, and hsa-miR-590-3p were identified. Hsa-miR-520e and hsa-miR-137 had 4 common TGs, including SNF related kinase, metal-regulatory transcription factor 1 (MTF1), round spermatid basic protein 1 and YTH N6-methyladenosine RNA binding protein 3; hsa-miR-590-3p and hsa-miR-137 had 14 common TGs, including NCK adaptor protein 1 (NCK1), EPH receptor A7, and stress-associated endoplasmic reticulum protein 1; hsa-miR-590-3p and hsa-miR-520e had 12 common TGs, including Krüppel-like factor (KLF) 13, twinfilin actin binding protein 1, and nuclear factor I B. Through the functional and pathway enrichments analysis, MTF1 was involved in regulation of gene expression and metabolic processes, and sequence-specific DNA binding TF activity. KLF13 was involved in regulation of gene expression and regulation of cellular metabolic processes. NCK1 was enriched in the axon guidance pathway. In addition, the functional and pathway enrichment analysis showed certain TGs, such as hypoxia-inducible factor 1α, AKT serine/threonine kinase 2, and rapamycin-insensitive companion of mammalian target of rapamycin, participated in the mTOR signaling pathway. The 3 key DEMs hsa-miR-137, hsa-miR-520e, and hsa-miR-590-3p may have important roles in the process of LS.
Keywords: Lynch syndrome; differentially expressed miRNA; regulatory network; target gene.
Figures

Similar articles
-
Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.Oncol Lett. 2019 Dec;18(6):6079-6089. doi: 10.3892/ol.2019.10941. Epub 2019 Sep 30. Oncol Lett. 2019. PMID: 31788082 Free PMC article.
-
Identification of MicroRNA-Target Gene-Transcription Factor Regulatory Networks in Colorectal Adenoma Using Microarray Expression Data.Front Genet. 2020 May 19;11:463. doi: 10.3389/fgene.2020.00463. eCollection 2020. Front Genet. 2020. PMID: 32508878 Free PMC article.
-
Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.Gene. 2018 Feb 5;642:205-211. doi: 10.1016/j.gene.2017.11.022. Epub 2017 Nov 8. Gene. 2018. PMID: 29128636
-
MicroRNA network analysis identifies key microRNAs and genes associated with precancerous lesions of gastric cancer.Genet Mol Res. 2014 Oct 27;13(4):8695-703. doi: 10.4238/2014.October.27.10. Genet Mol Res. 2014. PMID: 25366760
-
Identification of potential therapeutic target genes and miRNAs for primary myelofibrosis with microarray analysis.Exp Ther Med. 2017 Oct;14(4):2743-2750. doi: 10.3892/etm.2017.4912. Epub 2017 Aug 9. Exp Ther Med. 2017. PMID: 28966666 Free PMC article.
Cited by
-
Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.J Cell Mol Med. 2019 Nov;23(11):7299-7309. doi: 10.1111/jcmm.14582. Epub 2019 Sep 26. J Cell Mol Med. 2019. PMID: 31557418 Free PMC article.
-
CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.Open Med (Wars). 2019 Dec 4;14:913-919. doi: 10.1515/med-2019-0108. eCollection 2019. Open Med (Wars). 2019. PMID: 31934637 Free PMC article.
-
Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway.Onco Targets Ther. 2020 Oct 29;13:11045-11058. doi: 10.2147/OTT.S260499. eCollection 2020. Onco Targets Ther. 2020. PMID: 33149617 Free PMC article.
-
Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome.Int J Mol Sci. 2022 Apr 13;23(8):4284. doi: 10.3390/ijms23084284. Int J Mol Sci. 2022. PMID: 35457101 Free PMC article. Review.
-
MiR-137 Targets the 3' Untranslated Region of MSH2: Potential Implications in Lynch Syndrome-Related Colorectal Cancer.Cancers (Basel). 2021 Sep 17;13(18):4662. doi: 10.3390/cancers13184662. Cancers (Basel). 2021. PMID: 34572889 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous